Wird geladen...

Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial

BACKGROUND: Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment opt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trials
Hauptverfasser: Burmeister, Jan, Holle, Dagny, Bock, Eva, Ose, Claudia, Diener, Hans-Christoph, Obermann, Mark
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669653/
https://ncbi.nlm.nih.gov/pubmed/26634453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-1052-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!